Preliminary Conference Program

 

Wednesday, 16 January, 2019
All Day Exhibit Setup
10:00 – 19:00 Registration Open
10:00 – 18:00 Poster Setup
12:00 – 16:00 Toxins 101 Preconference Workshop
18:00 – 19:30 Opening Session
Chair: Giampietro Schiavo (UK)
18:00 – 18:30 Opening Remarks and Lifetime Achievement Awards Ceremony
18:30 – 19:00 Presentation by Basic Science Lifetime Achievement Award Recipient
19:00 – 19:30 Presentation by Clinical Lifetime Achievement Award Recipient
19:30 – 22:00 Welcome Reception

 

Thursday, 17 January, 2019
07:00 – 18:30 Registration/Information
07:00 – 08:30 Exhibits & Breakfast
08:30 – 12:00 Plenary Session
Pain and Sensory Mechanisms
Chair: Mark Hallett (USA)
08:30 – 08:40 Opening Remarks and Introduction of Keynote Speaker
08:40 – 09:30 Keynote Presentation
Stephen McMahon (UK)
09:30 – 10:00 Emerging Clinical Uses for BoNT in Relation to Pain
Nadine Attal (France)
10:00 – 10:30 Novel Analgesics
Zdravko Lackovic (Croatia)
10:30 – 11:00 BREAK
11:00 – 11:30 Headache
Cristina Tassorelli (Italy)
11:30 – 12:00 Central Effects in Sensory and Pain Networks
Rami Burstein (USA)
12:00 – 13:30 Lunch
12:00 – 14:30 Exhibits
12:00 – 14:30 Poster Session

 

PARALLEL TRACKS Basic Science Track Clinical Tracks 1A & 1B Clinical Workshops 1A & 1B Clinical Workshops 2A & 2B Clinical Workshops 3A & 3B Clinical Workshops 4A & 4B
14:30 – 16:00 Emerging Toxins and Toxin Engineering
Session Chair: Eric Johnson (USA)
Current and Emerging GI/GU Applications of BoNT
Session Chair: Michael Chancellor (USA)
Cosmetic and Dermatologic Uses of BoNT
Session Chair: Jonathan Sykes (USA)
Newly-Diagnosed Cervical Dystonia
Session Chair: Cindy Comella (USA)
Adult Spasticity
Session Chair: Alberto Esquenazi (USA)
Lower Cranial Dystonias and Drooling
Session Chair: Andrew Blitzer (USA)
14:30 – 15:00 What Defines a Botulinum Neurotoxin–Toxin Diversity
Eric Johnson (USA)
Clinical Applications in the Male GU Tract: Benign Prostatic Hyperplasia, Chronic Pelvic Pain Syndrome, Cancer
Emmanuel Chartier-Kastler (France)
Beyond the Wrinkles: New and Emerging Cosmetic Applications for Botulinum Toxin What to Say to a Newly Diagnosed Patient and How to Manage Expectations
Marie-Helene Marion (UK)

How to Advise a Patient with CD: Exercise, Daily Living, Retraining
Lena Zetterberg (Sweden)

Strategy for Starting BoNT Treatment (written consent, initial dose and subsequent doses, interval, follow-up)
Joseph Tsui (Canada)
From Benchmark to the Latest Clinical Data: Evidence for the Use of BoNT in the Upper Extremity
Jorg Wissel (Germany)

Evidence for the Use of BoNT in the Lower Extremity
Allison Brashear (USA)
Oromandibular and Laryngeal Dystonia
Andrew Blitzer (USA)
15:00 – 15:30 Discovery of Novel Botulinum Therapeutics: A Binary Approach
Bazbek Davletov (UK)
Potential Clinical Applications for BoNT in the GI Tract
Francois Mion (France)
Long-Term and Preventative Effects of Regular Cosmetic Neurotoxin Treatment The Comprehensive Approach to The Management of Spasticity: Chemodenervation and Adjunctive Therapies
Jean-Michel Gracies (France)
Dystonic Swallowing, Speech and Breathing Difficulties: What the Injector Needs to Know
Lucy Hicklin (UK)
15:30 – 16:00 2 Selected Podium Abstracts The Role of BoNT in “Classic” Bladder Disorders: Clinical Update
Christopher Smith (USA)
2 Selected Podium Abstracts Cervical Dystonia in Rotation: Different Injection Protocols for Different Clinical Phenotypes
Video Case Studies
Speaker: Joseph Jankovic (USA)
Challenging Patients with Progressive Spastic Paraparesis: Multiple Hospitals, Changing Neurotoxin Preparations: How Do You Maintain a Patient’s Standard of Care?
Francesco Scaglione (Italy)

The Anticoagulated Patient: Management Challenges
Chris Boulias (Canada)
Lip and Tongue Dystonia: “Drooling Along the Way”
Raymond Rosales (Philippines)
16:00 – 16:30 BREAK BREAK BREAK BREAK BREAK BREAK
16:30 – 18:30 Mode of Action of BoNTs
Session Chair: Mauricio Montal (USA)
Primary Headache
Cosmetic and Dermatologic Uses–Injection Workshop I
Moderator: Steve Yoelin (USA)
Cervical Dystonia Injection Workshop I
Moderator: Carlos Singer (USA)
Adult Spasticity Injection Workshop
Moderator: Anthony Ward (UK)
Oromandibular Dystonia and Spasmodic Dysphonia Injection Workshop
Moderator: Stewart Factor (USA)
16:30 – 17:00 Structural Insights into BoNT Receptor Interaction or Into BoNT Complexes
Richard Kammerer (Switzerland)
Pathophysiology of Migraine: Migraine Pain vs Other Types of Chronic Pain–Similarities and Differences
Anthony Dickenson (UK)
Demonstrations on Live Patients
Master Injector: Jesper Thulesen (Denmark)
Demonstrations on Live Patients
Master Injector: Torben Dalager (Denmark)
Demonstrations on Live Patients
Master Injector: Bo Biering-Sørensen (Denmark)
Demonstrations on Live Patients
Master Injector: Gohar Nikoghosyan-Bossen (Denmark)
17:00 – 17:30 2 Selected Podium Abstracts Episodic and Chronic Migraine: Is it Better to Revert Chronicity or Should We Aim at Preventing?: The Role of BoNT
17:30 – 18:00 Basic Biology of BoNTs
Suzanne Kalb (USA)
Predictors of Response to BoNT in Chronic Migraine
Patricia Pozo-Rosich (Spain)
18:00 – 18:30 2 Selected Podium Abstracts Video Case Studies 2 Selected Podium Abstracts

 

Friday, 18 January, 2019
07:00 – 08:30 Registration/ Information
07:00 – 08:30 Exhibits & Breakfast
08:30 – 12:00 Plenary Session
Duration of Action
Chairs: Matteo Caleo (Italy) & David Simpson (USA)
08:30 – 09:00 Clinical Duration of Action of Different Toxin Types
Roberto Eleopra (Italy)
09:00 – 09:30 Receptor Mechanisms (BoNT Receptor Interaction)
Andreas Rummel (Germany)
09:30 – 10:00 Are Booster Injections Safe?
Dirk Dressler (Germany)
10:00 – 10:30 Break
10:30 – 11:00 Cell Entry, Activation and Intracellular Persistence of BoNT Light Chains
Marco Pirazzini (Italy)
11:00 – 11:30 Duration of Action in Dermatology/Aesthetics
Shannon Humphrey (Canada)
11:30 – 12:00 Synaptic and Central Mechanisms Contributing to Duration (BoNT Trafficking in Neurons)
Fred Meunier (Australia)
12:00 – 13:30 Lunch
12:00 – 14:30 Exhibits
12:00 – 14:30 Poster Session

 

PARALLEL TRACKS
14:30 – 18:30
Basic Science Track Clinical Tracks 1A & 1B Clinical Workshops 1A & 1B Clinical Workshops 2A & 2B Clinical Workshops 3A & 3B Clinical Workshops 4A & 4B
14:30 – 16:00 Neuronal Plasticity and Trafficking of BoNTs
Session Chair: Matteo Caleo (Italy)
Clinical Utility of BoNT for Pain
Session Chair: Nadine Attal (France)
Cosmetic Applications of BoNT: Aesthetic and Therapeutic Considerations
Session Chair: Shannon Humphrey (Canada)
Cervical Dystonia II
Session Chair: Ryuji Kaji (Japan)
Pediatric Spasticity and Movement Disorders
Session Chair: Florian Heinen (Germany)
Hemifacial Spasm and Blepharospasm
Session Chair: Marie Vidailhet (France)
14:30 – 15:00 Neuronal Selectivity of BoNTs
Michel Popoff (France)
Post-Herpetic Neuralgia

Where Aesthetic Meets Therapeutic: Wrinkles, Migraine, Hemifacial Spasm and Blepharospasm: Treatment Considerations to Maximize Multiple Outcomes Anterocollis Posture and Deep Cervical Muscle Injections With BoNT
Laxman Bahroo (USA)
Review of Common Gait Patterns in Children With Cerebral Palsy The Patient’s Perspective: Personal Experience, Psychological Profile and Social Media
Marie Vidailhet (France)
15:00 – 15:30 Neuronal Plasticity and BoNTs as Pain Therapeutics
Stephen Hunt (London)
Temporomandibular Disorders and Trigeminal Neuralgia The Cosmetic Use of Botulinum Toxin to Correct Facial Asymmetry Cervical Dsytonia Revisited
Alberto Albanese (Italy)
Neurotoxin Therapy vs Physical Treatments: What Is the Optimal Approach for the Pediatric Patient? Blepharospasm and Hemifacial Spasm: Different Injection Protocols for Different Clinical Phenotypes
Video Case Studies
Marie-Helene Marion (UK)
15:30 – 16:00 2 Selected Podium Abstracts Painful Dystonias From Glabella to Platysma: Injection Techniques to Maximize Outcomes 2 Selected Podium Abstracts Common Hyperkinetic Movement Disorders in Children
Darcy Fehlings (Canada)
Facial Tics
Joseph Jankovic (USA)
16:00 – 16:30 BREAK BREAK BREAK BREAK BREAK BREAK
16:30 – 18:30 Protection and Detection
Session Chair: Sabine Pellett (USA)
Other Neurological Uses for BoNT
Session Chair: Francisco Cardoso (Brazil)
Focal Limb Dystonia Injection Workshop
Moderator: David Simpson (USA)
Cervical Dystonia Injection Workshop II
Moderator: Alberto Albanese (Italy)
Pediatric Spasticity Video Case Studies
Moderator: Cindy Ivanhoe (USA)
Hemifacial, Blepharospasm and Sialorrhea Injection Workshop
16:30 – 17:00 Vaccines to BoNT
Robert Webb (USA)
Management of Sialorrhea
Wolfgang Jost (Germany)
Focal Limb Dystonia and Tremor: Clinical Update
Mandar Jog (Canada)
Demonstrations on Live Patients
Master Injector: Theódora Hannesdóttir Cleemann (Denmark)
Cases Presented by:
Florian Heinen (Germany)
Cindy Ivanhoe (USA)
Sebastian Schroeder (Germany)
Demonstrations on Live Patients
Master Injector: Heidi Bryde Biernat (Denmark)
17:00 – 17:30 RNA-Based Therapeutics
Chuck Shoemaker (USA)
The Utility of BoNT in Parkinson’s–Beyond Sialorrhea
Fernando Pagan (USA)
Focal Limb Dystonia Injection Workshop
Moderator: Mark Hallett (USA)
17:30 – 18:00 Small Molecule Inhibitors to BoNTs
Kim Janda (USA)
2 Selected Podium Abstracts Demonstrations on Live Patients
Master Injector: Torben Dalager (Denmark)
18:00 – 18:30 2 Selected Podium Abstracts

 

Saturday, 19 January, 2019
07:00 – 08:30 Registration/ Information
07:00 – 08:30 Exhibits
09:00 – 11:15 Plenary Session
08:00 – 09:00 INA Members Business Meeting
09:00 – 11:15 New Toxins
Chair: Giampietro Schiavo (UK)
09:00 – 09:30 What Properties do Clinicians and Patients Want?
Jörg Wissel (Germany)
09:30 – 10:00 Family of BoNTs and New Toxins
Pål Stenmark (Sweden)
10:00 – 10:30 New Versions of BoNT Including Transdermal Preparations and Type E: New Clinical Indications: Ongoing Clinical Trials
Cindy Comella (USA)
10:30 – 11:00 Toxin Engineering
Min Dong (USA)
11:00 – 11:15 Conference Closing Remarks
Cindy Comella (USA)